Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors
Objective Sodium glucose cotransporter-2 inhibitors (SGLT2i) exert cardiorenal protection in people with diabetes. By inducing glycosuria, SGLT2i predispose to genital infections. In addition, rare occurrence of Fournier’s gangrene (FG) has been reported. We aimed to investigate such association thr...
Saved in:
| Main Authors: | Gian Paolo Fadini, Mayur Sarangdhar, Angelo Avogaro, Emanuel Raschi, Fabrizio De Ponti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-05-01
|
| Series: | BMJ Open Diabetes Research & Care |
| Online Access: | https://drc.bmj.com/content/7/1/e000725.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TREATMENT OF PATIENTS WITH GANGRENE FOURNIER
by: O. B. Priyma
Published: (2017-02-01) -
Fournier Gangrene Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Pharmacovigilance Study with Data from the U.S. FDA Adverse Event Reporting System
by: Yang Hu, et al.
Published: (2020-01-01) -
Fournier’s Gangrene Mortality Index (FGMI): A New Scoring System for Predicting Fournier’s Gangrene Mortality
by: Hüseyin Yönder, et al.
Published: (2024-12-01) -
PREDISPOSITION FACTORS ANALYSIS FOR FOURNIER'S GANGRENE DEFECTS CLOSURE COMPLICATION
by: Bayu Fasi Bermani, et al.
Published: (2020-06-01) -
Fournier’s Gangrene of the Penis following a Human Bite Wound
by: Tyler Overholt, et al.
Published: (2018-01-01)